Jane Street
NEUP

Jane Street’s Neuphoria Therapeutics NEUP Stock Holding History

Jane Street’s Portfolio NEUP Stock Details NEUP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$65.1K Buy
+14,903
New +$71.9K ﹤0.01% 10820
2026
Q1 		– Sell
-16,597
Closed -$64.4K – 13373
2025
Q4 		$64.4K Buy
16,597
+928
+6% +$6.59K ﹤0.01% 10405
2025
Q3 		$185K Buy
+15,669
New +$145K ﹤0.01% 9740
2025
Q1 		– Sell
-13,311
Closed -$45.7K – 11010
2024
Q4 		$45.7K Buy
+13,311
New +$47K ﹤0.01% 8992

Other funds holding NEUP

LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Jane Street's NEUP Position: Q2 2026 in Review

Jane Street opened a new position in Neuphoria Therapeutics (NEUP) in Q2 2026: 14,903 shares worth $65.1K. The stake represents ﹤0.01% of the portfolio and ranks #10820 among its holdings. This is a return to the name: Jane Street previously reported a position in NEUP as recently as Q4 2025.

Jane Street first reported a position in NEUP in Q4 2024 and has held it in 4 quarters since. The position peaked at $185K in Q3 2025. 22 funds tracked by Wall St. Rank hold NEUP as of Q2 2026.

  • Jane Street held 14,903 shares of Neuphoria Therapeutics worth $65.1K as of Q2 2026.
  • Neuphoria Therapeutics was a new Jane Street position in Q2 2026.
  • Neuphoria Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #10820 holding.
  • Jane Street first reported a position in Neuphoria Therapeutics in Q4 2024 and has held it in 4 quarters since.
  • Jane Street's Neuphoria Therapeutics position peaked at $185K in Q3 2025.
  • 22 funds tracked by Wall St. Rank held Neuphoria Therapeutics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.